Skip to main content
. 2020 Sep 2;9(9):725. doi: 10.3390/pathogens9090725

Table 1.

Immunocompromised patients infected with the dual H275Y mutant influenza A(H1N1)pdm09 viruses.

Isolate Name Date of Symptom Onset
(Day/Month/Year)
Antiviral Administration
(Day/Month/Year)
Date of Specimen Collection
(Day/Month/Year)
NA Substitution
A/Hiroshima/57/2014 31-03-2014 31-03-2014: Peramivir
04-04-2014: Laninamivir
04-04-2014 H275Y/I223R
A/Ibaraki/54/2016 09-02-2016 09-02-2016: Peramivir
24-02-2016 to 03-03-2016: Peramivir
26-02-2016 to 03-03-2016: Oseltamivir
05-03-2016: Laninamivir
07-03-2016 H275Y/I223K
A/Hiroshima/13/2016 26-02-2016 23-02-2016: Laninamivir
26-02-2016 to 01-03-2016: Peramivir
07-03-2016 to 11-03-2016: Peramivir
28-03-2016 to 01-04-2016: Peramivir
11-03-2016 H275Y/G147R

NA: neuraminidase.